Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR3 |
Variant | S131L |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | FGFR3 S131L lies within the extracellular domain of the Fgfr3 protein (UniProt.org). The functional effect of S131L is conflicting, as it results in decreased proliferation and cell viability compared to wild-type Fgfr3 in one study (PMID: 29533785), however, in another study, demonstrates increased cell proliferation under some cell culture conditions (PMID: 27053219), and therefore, its effect on Fgfr3 protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
FGFR3 mutant FGFR3 S131L |
Transcript | NM_000142.5 |
gDNA | chr4:g.1799759C>T |
cDNA | c.392C>T |
Protein | p.S131L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_006713870 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713870.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_011513422.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_001354810.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713868.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_047449822.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_000142 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_001163213.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_011513420.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713870.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713868 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713869 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_047449821.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713872 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_000142.4 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713871 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_022965.3 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_011513422 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713873 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_011513422.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713873.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_047449824.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713873.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_011513420.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_047449823.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713871.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_001354809.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_001354810.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_000142.5 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_001163213 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713871.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_022965 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_001354809.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713869.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_011513420 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713868.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_022965.4 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
NM_001163213.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_006713869.2 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
XM_047449820.1 | chr4:g.1799759C>T | c.392C>T | p.S131L | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FGFR3 S131L | head and neck squamous cell carcinoma | decreased response | Infigratinib | Preclinical - Cell culture | Actionable | In a preclinical study, a head and neck squamous cell carcinoma cell line expressing FGFR3 S131L demonstrated decreased sensitivity to Truseltiq (infigratinib) compared to cells expressing wild-type FGFR3 in culture (PMID: 27053219). | 27053219 |